[1] 杨成民,刘进,赵桐茂. 中华输血学[M]. 第2版. 北京:人民卫生出版社, 2022:995-998. [2] Malik H,Verweij E J T J,Mustafa H J. Hemolytic disease of the fetus and newborn: A review of pathophysiology, diagnosis,and management[J]. Best Pract Res Clin Obstet Gynaecol,2025,102:102646. [3] 陈清艳,王秋实. 新生儿溶血病发病机制及产前诊断研究进展[J]. 临床输血与检验,2021,23(5):578-584. [4] Jackson M E,Baker J M.Hemolytic disease of the fetus and newborn: historical and current state[J]. Clin Lab Med,2021,41(1):133-151. [5] 中国输血协会免疫血液学专业委员会. 胎儿新生儿溶血病实验室检测专家共识[J]. 临床输血与检验,2021,23(1): 20-24. [6] Talwar M,Jain A,Sharma R R,et al.The spectrum of ABO haemolytic disease of the fetus and newborn in neonates born to group O mothers[J]. Vox Sang,2022, 117(9):1112-1120. [7] Katsuragi S,Ohto H,Yoshida A,et al.Anemic disease of the newborn with little increase in hemolysis and erythropoiesis due to maternal anti-jra: a case study and review of the literature[J]. Transfus Med Rev,2019, 33(3):183-188. [8] Zwiers C,van Kamp I,Oepkes D,et al. Intrauterine transfusion and non-invasive treatment options for hemolytic disease of the fetus and newborn-review on current management and outcome[J]. Expert Rev Hematol,2017,10(4):337-344. [9] Palmeira P,Costa-Carvalho B T,Arslanian C,et al. Transfer of antibodies across the placenta and in breast milk from mothers on intravenous immunoglobulin[J]. Pediatr Allergy Immunol,2009,20(6):528-535. [10] Palmeira P,Quinello C,Silveira-Lessa A L,et al. IgG placental transfer in healthy and pathological pregnancies[J]. Clin Dev Immunol,2012,2012:985646. [11] Valentini B,Ramirez Zegarra R,Ghi T,et al.Red blood cell alloimmunization and pregnancy: Diagnosis and management[J]. Pregnancy,2025,1(5):e70085. [12] Malek A,Sager R,Kuhn P,et al.Evolution of maternofetal transport of immunoglobulins during human pregnancy[J]. Am J Reprod Immunol,1996,36(5): 248-255. [13] Atyeo C,Alter G.The multifaceted roles of breast milk antibodies[J]. Cell,2021,184(6):1486-1499. [14] Ohto H,Nollet K E,Storry J R.Five pathogenetic classifications for alloimmune hemolytic disease of the fetus and newborn[J]. Transfus Med Rev,2026,40(1): 150958. [15] Rio-Aige K,Azagra-Boronat I,Castell M,et al.The breast milk immunoglobulinome[J]. Nutrients,2021,13(6):1810. [16] Verhasselt V,Tellier J,Carsetti R,et al.Antibodies in breast milk: Pro-bodies designed for healthy newborn development[J]. Immunol Rev,2024,328(1):192-204. [17] Al Nabhani Z.Timing matters: maternal milk IgG sets weaning threshold[J]. Trends Mol Med,2025,31(12): 1067-1069. [18] Leuridan E,Hens N,Hutse V,et al.Kinetics of maternal antibodies against rubella and Varicella in infants[J]. Vaccine,2011,29(11):2222-2226. [19] Czosnykowska-Łukacka M,Lis-Kuberka J,Królak-Olejnik B,et al. Changes in human milk immunoglobulin profile during prolonged lactation[J]. Front Pediatr, 2020,8:428. [20] Kumar S,Rasalam J E,David V T,et al.Breast milk contains red cell isohaemagglutinins: An observational study of 176 mothers[J]. Vox Sang,2022,117(6):847-852. [21] Abels E,Jacobs J W,Prior D,et al.Passive transfer of alloantibodies through breast milk as a mediator of hemolytic anemia[J]. Transfusion,2023,63(11):2188-2196. [22] Guinn D,Kratz K,Baisden K,et al.On placental and lactational transfer of IgG-based therapeutic proteins-Current understanding and knowledge gaps from a clinical pharmacology perspective[J]. Clinical Translational Sci,2024,17(10):e70049. [23] Cianga P,Medesan C,Richardson J A,et al.Identification and function of neonatal Fc receptor in mammary gland of lactating mice[J]. Eur J Immunol,1999,29(8):2515-2523. [24] Maertens K,De Schutter S,Braeckman T,et al.Breastfeeding after maternal immunisation during pregnancy: Providing immunological protection to the newborn: A review[J]. Vaccine,2014,32(16):1786-1792. [25] Pyzik M,Sand K M K,Hubbard J J,et al. The neonatal fc receptor (FcRn): a misnomer?[J]. Front Immunol,2019, 10:1540. [26] Pyzik M,Kozicky L K,Gandhi A K,et al.The therapeutic age of the neonatal Fc receptor[J]. Nat Rev Immunol, 2023,23(7):415-432. [27] Rodewald R. pH-dependent binding of immunoglobulins to intestinal cells of the neonatal rat[J]. J Cell Biol, 1976,71(2):666-669. [28] Rodewald R.Intestinal transport of antibodies in the newborn rat[J]. J Cell Biol,1973,58(1):189-211. [29] He W Z,Ladinsky M S,Huey-Tubman K E,et al. FcRn-mediated antibody transport across epithelial cells revealed by electron tomography[J]. Nature,2008, 455(7212):542-546. [30] Roopenian D C,Akilesh S.FcRn: the neonatal Fc receptor comes of age[J]. Nat Rev Immunol,2007,7(9): 715-725. [31] Israel E J,Taylor S,Wu Z,et al.Expression of the neonatal Fc receptor,FcRn,on human intestinal epithelial cells[J]. Immunology,1997,92(1):69-74. [32] Christensen R D,Bahr T M,Ohls R K,et al.Erythrokinetic mechanism(s) causing the "late anemia" of hemolytic disease of the fetus and newborn[J]. J Perinatol,2024,44(6):916-919. [33] Demers-Mathieu V,Underwood M A,Beverly R L,et al.Comparison of human milk immunoglobulin survival during gastric digestion between preterm and term infants[J]. Nutrients,2018,10(5):631. [34] Hauschner H,Rosenberg N,Seligsohn U,et al.Persistent neonatal thrombocytopenia can be caused by IgA antiplatelet antibodies in breast milk of immune thrombocytopenic mothers[J]. Blood,2015,126(5):661-664. [35] Santhanakrishnan M,Tormey C A,Natarajan P,et al.Clinically significant anti-KEL RBC alloantibodies are transferred by breast milk in a murine model[J]. Vox Sang,2016,111(1):79-87. [36] DeMoss P,Asfour M,Hersey K. Anti-K1 (kell) antibody expressed in maternal breastmilk: a case report of a neonate with multiple intrauterine transfusions and postnatal exposure to kell antibody in maternal breastmilk[J]. Case Rep Pediatr,2017,2017:6927813. [37] Li M,Blaustein J C.Persistent hemolytic disease of the fetus and newborn (HDFN) associated with passive acquisition of anti-D in maternal breast milk[J]. Transfusion,2017,57(9):2121-2124. [38] Leonard A,Hittson Boal L,Pary P,et al.Identification of red blood cell antibodies in maternal breast milk implicated in prolonged hemolytic disease of the fetus and newborn[J]. Transfusion,2019,59(4):1183-1189. [39] Kaya Z,Yasar Y,Goral S,et al.Hemolysis in two newborns due to isohemagglutinins passively transferred from maternal breast milk[J]. Indian J Hematol Blood Transfus,2020,36(3):580-581. [40] Rasalam J E,Kumar S,Amalraj P,et al.Do red cell alloantibodies continue to challenge breast fed babies?[J]. Transfus Med,2020,30(4):281-286. [41] Sahni A,Karumannan V,Singh L,et al.Breast milk induced immune haemolytic disease of newborn due to anti-c: A case report[J]. Transfus Apher Sci,2024,63(5): 103974. [42] Gupta G K,Balbuena-Merle R,Hendrickson J E,et al.Immunohematologic aspects of alloimmunization and alloantibody detection: A focus on pregnancy and hemolytic disease of the fetus and newborn[J]. Transfus Apher Sci,2020,59(5):102946. [43] Wabnitz H,Cruz-Leal Y,Lazarus A H.Antigen copy number and antibody dose can determine the outcome of erythrocyte alloimmunization inducing either antibody-mediated immune suppression or enhancement in a murine model[J]. Transfusion,2023,63(4):696-702. [44] Debeer A,Vanhole C.Early postnatal management of neonatal RBC alloimmunization[J]. Best Pract Res Clin Obstet Gynaecol,2025,102:102651. [45] Kilby M D,Bussel J B,Moise K J Jr. The contemporary management of haemolytic disease of the fetus and newborn[J]. Vox Sang,2025,120(7):644-652. [46] 中华医学会儿科学分会新生儿学组,中华儿科杂志编辑委员会,杜立中,等. 新生儿高胆红素血症诊治指南(2025)[J]. 中华儿科杂志,2025,63(4):338-350. [47] Voto L,Gonzalez C A,Gonzalez S.Hemolytic disease of the fetus and newborn: pregnant person's and fetal immune systems interaction[J]. J Perinat Med,2025, 53(6):702-705. [48] Strauss R G,Storry J R.More data needed to establish maternal breast milk IgG as cause for anti-D hemolytic disease of fetus and newborn[J]. Transfusion,2018,58(3): 828-829. [49] Tjoa M L,Orillion A,Mankoski R,et al.Study design of the global prospective hemolytic disease of the fetus and newborn registry (GERANIUM)[J]. Am J Perinatol, 2026,43(13):1731-1738. [50] Drozdowska-Szymczak A,Łukawska S,Mazanowska N, et al.Management and treatment outcomes of hemolytic disease of the fetus and newborn (HDFN)-a retrospective cohort study[J]. J Clin Med,2024,13(16):4785. |